Circulars and decisions

SFDA Announcement Rejected Claims Labeling of Foodstuff

SFDA requirements for labeling and Packaging for investigational medicinal products (IMP)

SFDA Statement About The Recent Updates Concerning Safe Use Of Azithromycin

Stop receiving marketing authorization application MDMA via GHTF route

The Process for Receiving Requests in the Path of Non-sterile, Non-measuring Low Risk Medical Devices

The risk of rhabdomylosis/myopathy associated with the concomitant use of Simvastatin and Gemfibrozil

The Risk of using Fleet ready to use enema in patients under 2 years old

The use of Hydroxyethyl starch and risk of kidney injury and mortality in certain patient population

Universal access to the approval of the Gaza Aldoaand carry out insurance medicine (New)

Updates on Safety Information of Fentanyl Patches (Duragesic®)

Updates on the compliance timeframe for the requirements of medical devices unique device identification (Saudi -DI)

Updating the requirements for approval of advertising for medical devices and fees